For: | Chen LC, Lin HY, Hung SK, Chiou WY, Lee MS. Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2434-2457 [PMID: 34092968 DOI: 10.3748/wjg.v27.i20.2434] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v27/i20/2434.htm |
Number | Citing Articles |
1 |
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy. Journal of Clinical and Translational Hepatology 2022; 10(1): 147 doi: 10.14218/JCTH.2021.00179
|
2 |
Yongjian Guo, Jingqiang Wu, Licong Liang, Kangshun Zhu, Jingwen Zhou, Liteng Lin, Ye Chen, Bihui Cao, Mingji He, Hui Lian, Wensou Huang, Mingyue Cai. Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00604-4
|
3 |
So Jung Lee, Myungsoo Kim, Yoo-Kang Kwak, Hye Jin Kang. MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety. Journal of Cancer Research and Clinical Oncology 2022; 148(9): 2405 doi: 10.1007/s00432-021-03788-z
|
4 |
Jing‐Long Cao, Shu‐Mei Li, Yan‐Jun Tang, Wen‐Shuang Hou, An‐Qi Wang, Tian‐Zhu Li, Cheng‐Hao Jin. Network pharmacology analysis and experimental verification of the antitumor effect and molecular mechanism of isocryptomerin on HepG2 cells. Drug Development Research 2024; 85(2) doi: 10.1002/ddr.22165
|
5 |
Jeong Il Yu, Wonseok Kang, Gyu Sang Yoo, Myung Ji Goh, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jung Yong Hong, Ho Yeong Lim, Boram Park, Hee Chul Park. Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.888755
|
6 |
Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi. Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma. Cancers 2023; 15(13): 3347 doi: 10.3390/cancers15133347
|
7 |
Maryam Asadat Hashemipour, Ali Ezadi, Ava Roshani, Amir Reza Gandjalikhan Nassab. Side Effects of Radiation Therapy in Patients with Head and Neck Cancer According to the Late Effects of Normal Tissues-Subjective Objective Management and Analytic Questionnaire. Meandros Medical and Dental Journal 2023; 24(3): 226 doi: 10.4274/meandros.galenos.2023.10438
|
8 |
Hon-Yi Lin, Chih-Chia Yu, Chen-Lin Chi, Chang-Kuo Wei, Wen-Yao Yin, Chih-En Tseng, Szu-Chin Li. Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer. Cancers 2023; 15(16): 4131 doi: 10.3390/cancers15164131
|
9 |
Rui Xing, Jinping Gao, Qi Cui, Qian Wang. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.783236
|
10 |
Xi Chen, Letao Lin, Guanyu Chen, Huzheng Yan, Zhenyu Li, Meigui Xiao, Xu He, Fujun Zhang, Yanling Zhang. High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.900671
|
11 |
Anqi Zhang, Lei Gao. The Refined Application and Evolution of Nanotechnology in Enhancing Radiosensitivity During Radiotherapy: Transitioning from Gold Nanoparticles to Multifunctional Nanomaterials. International Journal of Nanomedicine 2023; : 6233 doi: 10.2147/IJN.S436268
|
12 |
蕊雨 郭. Advances of High-Intensity Focused Ultrasound Ablation in the Treatment of Primary Liver Cancer. Advances in Clinical Medicine 2023; 13(03): 3234 doi: 10.12677/ACM.2023.133460
|
13 |
Lin Sun, Huangxing Cai, Tengchao Zhou, Hua Xiang, Lin Long. Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR‐101‐3p/Wee1 axis. Drug Development Research 2022; 83(4): 891 doi: 10.1002/ddr.21914
|
14 |
Sakue Masuda, Toshitaka Tsukiyama, Yumiko Minagawa, Kazuya Koizumi, Makoto Kako, Takeshi Kinbara, Uojima Haruki. Hepatocellular carcinoma effective stereotactic body radiotherapy using Gold Anchor and the Synchrony system: Two case reports and review of literature. World Journal of Clinical Cases 2022; 10(8): 2591-2603 doi: 10.12998/wjcc.v10.i8.2591
|
15 |
Liqiu Kou, Xiaolu Xie, Xiu Chen, Bo Li, Jun Li, Yaling Li. The progress of research on immune checkpoint inhibitor resistance and reversal strategies for hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2023; 72(12): 3953 doi: 10.1007/s00262-023-03568-3
|
16 |
Jiaxi Zheng, Minghai Shao, Weifang Yang, Justin Ren, Xiaofeng Chen, Haihua Yang. Benefits of combination therapy with immune checkpoint inhibitors and predictive role of tumour mutation burden in hepatocellular carcinoma: A systematic review and meta-analysis. International Immunopharmacology 2022; 112: 109244 doi: 10.1016/j.intimp.2022.109244
|